Diebold Nixdorf, Incorporated (DBD)
(Delayed Data from NYSE)
$32.60 USD
+0.57 (1.78%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $32.60 0.00 (0.00%) 7:32 PM ET
1-Strong Buy of 5 1
A Value B Growth F Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DBD 32.60 +0.57(1.78%)
Will DBD be a Portfolio Killer in April?
Zacks Investment Research is releasing its prediction for DBD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DBD
Check Point (CHKP) Q1 Earnings & Sales Beat Expectations
SNAP Q1 Earnings Surpass Estimates, Revenues Increase Y/Y
DBD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Archrock and Diebold Nixdorf have been highlighted as Zacks Bull and Bear of the Day
Bear Of The Day: Diebold Nixdorf, Incorporated (DBD)
Investors Heavily Search Diebold Nixdorf, Incorporated (DBD): Here is What You Need to Know
Other News for DBD
Diebold Nixdorf Announces Thomas Timko as Chief Financial Officer
Analysts Conflicted on These Technology Names: Diebold Nixdorf Inc (DBD), Adyen (OtherADYYF) and Alight (ALIT)
Diebold Nixdorf announces Thomas Timko as CFO
Diebold names Thomas Timko as CFO, succeeding Jim Barna
Four new option listings on April 17th